Tag Archive for: Galapagos

a-c-J4-AEzy08ss-unsplashA. C. via Unsplash+
Financing

Coultreon bags US$125m for autoimmune pipeline

Belgian Coultreon Biopharma has raised US$125m in a big‑pharma‑backed Series A round to push its first‑in‑class SIK3 inhibitor into Phase II after an ongoing Phase I programme in autoimmune disease

Read more
Principle of TCR-T cell therapyAdaptimmune
Clinical trials

Adaptimmune nears second approval for TCR-T therapy

After meeting the primary endpoints of a pivotal Phase II trial, UK-based Adaptimmune Ltd. is submitting an FDA Biologics License Application for its autologous T-cell receptor therapy (TCR-T) Lete-cel (letetresgene autoleucel).

Read more